Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Document Details
Form
Filing Date
Nov 4, 2020
Document Date
Nov 2, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
Mahoney Stephen F.